| 國家衛生研究院 |
2012 |
TCF12過度表現及其促進大腸直腸癌轉移之機轉探討
|
黃智興;陳維熊 |
| 輔英科技大學 |
2006-08-01 |
TCF4與乙型卡特林因子調控去毒蛋白MDR1, UGT1A1與OATP2在肝癌組織細胞中表現之研究以及在臨床診斷治療之應用
|
曹德安;張慧柔 |
| 高雄醫學大學 |
2003 |
Tcf4轉入因子在不同腦瘤中的差異性表現
|
洪義人;黃旭霖;思偉玓;劉安祥;黃祖源;洪純隆 |
| 國立臺灣大學 |
2008 |
Tcf7l2 Genetic Variant Is Associated with Insulin Resistance-Related Traits in the Chinese Population
|
邱燕楓; 張恬君; 何橈通; 莊立民; CHIU, YEN-FENG; CHANG, TIEN-JYUN; HO, LO-TONE; CHUANG, LEE-MING |
| 國家衛生研究院 |
2010-02 |
TCF7L2 genetic variants and progression to diabetes in the Chinese population: pleiotropic effects on insulin secretion and insulin resistance
|
Chang, YC;Chiu, YF;Ho, LLT;Ting, CT;Shih, KC;Curb, JD;Chen, YDI;Li, HY;Chuang, LM |
| 國立臺灣大學 |
2010 |
Tcf7l2 Genetic Variants and Progression to Diabetes in the Chinese Population: Pleiotropic Effects on Insulin Secretion and Insulin Resistance
|
張以承; 邱燕楓; 何橈通; 丁紀台; 石光中; 陳以德; 李弘元; 莊立民; CHANG, I-CHERN; CHIU, YEN-FENG; HO, LO-TONE; TING, CHIH-TAI; SHIH, KUANG-CHUNG; CHEN, YII-DER I.; LI, HUNG-YUAN; CHUANG, LEE-MING |
| 臺大學術典藏 |
2022-03-10T05:59:45Z |
TCF7L2 genetic variants and progression to diabetes in the Chinese population: Pleiotropic effects on insulin secretion and insulin resistance
|
YI-CHENG CHANG; Chiu Y.-F.; Ho L.L.-T.; Ting C.-T.; Shih K.-C.; Curb J.D.; Chen Y.-D.I.; Li H.-Y.; Chuang L.-M. |
| 高雄醫學大學 |
2009 |
TCF7L2 rs290487基因多型性與第2型糖尿病白蛋白尿之關聯性
|
張維君;王巧伶;林幸宜;何馨如;林昆德;張毓泓;蕭璧容;辛錫璋 |
| 淡江大學 |
2025-12-04 |
TCFD Compliance and Decarbonization Practices: Evidence From Taiwan's Financial Institutions
|
Hsiao, Ching-Yuan;Shiu, Yung-Ming |
| 國立成功大學 |
2025-06-10 |
TCFD框架下全球機場實體氣候風險之地理依存性
|
蘇筱容; Su, Xiao-Rong |
| 國立交通大學 |
2014-12-08T15:26:32Z |
TCG-S: Orthogonal coupling of P*-admissible representations for general floorplans
|
Lin, JM; Chang, YW |
| 國立交通大學 |
2014-12-08T15:39:05Z |
TCG-S: Orthogonal coupling of P*-admissible representations for general floorplans
|
Lin, JM; Chang, YW |
| 臺大學術典藏 |
2018-09-10T04:53:44Z |
TCG-S: Orthogonal coupling of P*-admissible representations for general floorplans
|
Lin, J.-M.; Chang, Y.-W.; YAO-WEN CHANG |
| 臺大學術典藏 |
2004 |
TCG-S: Orthogonal Coupling of P^*-Admissible Representations for General Floorplans
|
Lin, Jai-Ming; Chang, Yao-Wen; Lin, Jai-Ming; Chang, Yao-Wen |
| 國立臺灣大學 |
2004 |
TCG-S: Orthogonal Coupling of P^*-Admissible Representations for General Floorplans
|
Lin, Jai-Ming; Chang, Yao-Wen |
| 臺大學術典藏 |
2005 |
TCG: A transitive closure graph based representation for general floorplans
|
Lin, Jai-Ming; Chang, Yao-Wen; Lin, Jai-Ming; Chang, Yao-Wen |
| 國立臺灣大學 |
2005 |
TCG: A transitive closure graph based representation for general floorplans
|
Lin, Jai-Ming; Chang, Yao-Wen |
| 臺大學術典藏 |
2018-09-10T05:23:28Z |
TCG: A transitive closure graph-based representation for general floorplans
|
Lin, J.-M.; Chang, Y.-W.; YAO-WEN CHANG |
| 國立交通大學 |
2014-12-08T15:26:48Z |
TCG: A transitive closure graph-based representation for non-slicing floorplans
|
Lin, JM; Chang, YW |
| 國立交通大學 |
2014-12-08T15:34:24Z |
TCGA 2013 COMPUTER GAME TOURNAMENT REPORT
|
Tseng, Wen-Jie; Chen, Jr-Chang; Chen, Lung-Ping; Yen, Shi-Jim; Wu, I-Chen |
| 國立交通大學 |
2019-04-03T06:38:35Z |
TCGA 2014 COMPUTER GAME TOURNAMENT
|
Lin, Shun-Shii; Chen, Chih-Hung; Hsu, Shun-Chin; Wu, I-Chen; Yen, Shi-Jim; Chen, Jr-Chang |
| 國立成功大學 |
2024 |
TCGNN: Text-Clustering Graph Neural Networks for�Fake News Detection on�Social Media
|
Li;P, -C.;Li;C, -T. |
| 國立成功大學 |
2013-04 |
TCH-1030 targeting on topoisomerase I induces S-phase arrest, DNA fragmentation, and cell death of breast cancer cells
|
Liu, Yu-Peng; Chen, Hui-Ling; Tzeng, Cherng-Chyi; Lu, Pei-Jung; Lo, Cheng-Wei; Lee, Yu-Cheng; Tseng, Chih-Hua; Chen, Yeh-Long; Yang, Chia-Ning |
| 國立臺灣大學 |
2012 |
TCL Trading Company企業計畫
|
林佳緯; Lin, Chia-wei |
| 國立成功大學 |
2007-07 |
TCL1 in B-cell tumors retains its normal B-cell pattern of regulation and is a marker of differentiation stage
|
Herling, Marco; Patel, Kaushali A.; Hsi, Eric D.; Chang, Kong-Chao; Rassidakis, George Z.; Ford, Richard; Jones, Dan |
| 亞洲大學 |
2011-02 |
TCM Database@Taiwan: The World's Largest Traditional Chinese Medicine Database for Drug Screening in Silico
|
陳語謙;Chen, Calvin Yu-Chian |
| 中國醫藥大學 |
2011-01 |
TCM Database@Taiwan: The World’s Largest Traditional Chinese Medicine Database for Drug Screening In Silico
|
陳語謙(Calvin Yu-Chian Chen)* |
| 元培科技大學 |
2021-03-26 |
TCM Health Management, to Create a Beautiful China
|
Xin, He-yu |
| 中國醫藥大學 |
2011-10-10 |
TCM treatment for asthma in children
|
顏宏融(Hung-Rong Yen)*;顏宏融(Hung-Rong Yen) |
| 國立臺灣大學 |
1986 |
TCM 模式使用手冊
|
梁文傑; Liang, Wen-Jey |
| 中國醫藥大學 |
2008-08-28 |
TCM-1 Protects BV-2 microglial cells from ischemia damage: action and mechanism approach
|
陳玉芳(Yuh-Fung Chen)*; 林玟玲(Wen-Ling Lin); 蔡輝彥(Huei-Yann Tsai) |
| 中國醫藥大學 |
2008-11-22 |
TCM-1 Protects BV-2 microglial cells from ischemia damage: action and mechanism approach
|
林玟玲(Wen-Ling Lin); (Huei-Yann); (Yuh-Fung Chen) |
| 中國醫藥大學 |
2007-12-02 |
TCM-1 protects neuronal cells against ischemia insult
|
陳玉芳(Yuh-Fung Chen); 蔡輝彥(Huei-Yann Tsai) |
| 中國醫藥大學 |
2006-11-04 |
TCM-1 protects neuronal cells against ischemia insult
|
陳玉芳(Chen,Yuh-Fung) |
| 中國醫藥大學 |
2008-07-14 |
TCM-1對缺血所致BV-2小神經膠質細胞傷害之保護作用及機轉探討; TCM-1 Protects BV-2 microglial cells from ischemia damage: action and mechanism approach
|
林玟玲; Wen-Ling Lin |
| 中國醫藥大學 |
2008-03-29 |
TCM1 protects BV2 microglial cells against serum-oxygen-glucose deprivation via multiple mechanisms
|
林玟玲(Wen-Ling Lin); 蔡輝彥(Huei-Yann Tsai); 陳玉芳(Yuh-Fung Chen)* |
| 中原大學 |
2003-07-03 |
TCMAC應用於函數逼近及馬達控制
|
鄭鴻業; Hung-Yeh Cheng |
| 國立臺灣大學 |
2008 |
TCMGeneDIT: a Database for Associated Traditional Chinese Medicine, Gene and Disease Information Using Text Mining
|
Fang, Yu-Ching; Huang, Hsuan-Cheng; Chen, Hsin-Hsi; Juan, Hsueh-Fen |
| 臺大學術典藏 |
2018-09-10T06:56:51Z |
TCMGeneDIT: a database for associated traditional Chinese medicine, gene and disease information using text mining
|
Fang, Yu-Ching;Huang, Hsuan-Cheng;Chen, Hsin-Hsi;Juan, Hsueh-Fen; Fang, Yu-Ching; Huang, Hsuan-Cheng; Chen, Hsin-Hsi; Juan, Hsueh-Fen |
| 臺大學術典藏 |
2020-02-19T07:21:24Z |
TcMYB1, TcMYB4, and TcMYB8 participate in the regulation of lignan biosynthesis in Taiwania cryptomerioides Hayata
|
Chiang N.-T.;Wen C.-H.;Chu F.-H.; Chiang N.-T.; Wen C.-H.; Chu F.-H.; FANG-HUA CHU |
| 臺大學術典藏 |
2019-09-09T00:54:25Z |
TcMYB1, TcMYB4, and TcMYB8 participate in the regulation of lignan biosynthesis in Taiwania cryptomerioides Hayata
|
Wen, Chi Hsiang;Chiang, Nien Ting;FANG-HUA CHU; Wen, Chi Hsiang; Chiang, Nien Ting; FANG-HUA CHU; Wen, Chi Hsiang; Chiang, Nien Ting; FANG-HUA CHU; FANG-HUA CHU |
| 臺大學術典藏 |
2002 |
TCN: Scalable hierarchical hypercubes
|
Lee, T.-Y.; Hsiung, P.-A.; Chen, S.-J.; SAO-JIE CHEN |
| 臺大學術典藏 |
2018-09-10T15:19:53Z |
TCO-free conducting polymers/carbon cloths as the flexible electro-catalytic counter electrodes for dye-sensitized solar cells
|
KUO-CHUAN HO;Ho, K.-C.;Chiu, I.-T.;Lin, Y.-F.;Li, C.-T.;KUO-CHUAN HO; Li, C.-T.; Lin, Y.-F.; Chiu, I.-T.; Ho, K.-C.; KUO-CHUAN HO |
| 國立成功大學 |
2012-06-04 |
TCO/p界面對矽薄膜太陽能電池之影響
|
張評款; Chang, Ping-Kuan |
| 國立成功大學 |
2012-05-04 |
TCO/p界面對矽薄膜太陽能電池之影響
|
張評款; Chang, Ping-Kuan |
| 國家衛生研究院 |
2018-11 |
TCOG T1308 study: The final results of a phase II trial of modified gemcitabine plus S-1 combination as the first-line treatment in patients with advanced biliary tract cancer
|
Chiang, NJ;Chen, LT;Chen, JS;Yang, SH;Hsu, C;Shan, YS;Yen, CJ;Chen, MH;Tsou, HH |
| 國家衛生研究院 |
2024-10 |
TCOG T3221 study: The registry of genetic alterations of Taiwan biliary tract cancer
|
Chiang, N;Hsu, C;Chen, J;Dai, M;Bai, L;Yen, C;Wang, T;Hsieh, Y;Lin, J;Chiu, T;Cheng, H;Yang, Y;Hsiao, C;Chen, L;Chen, M |
| 國立成功大學 |
2024-10 |
TCOG T3221 study: the registry of genetic alterations of Taiwan biliary tract cancer
|
Chiang;N;Hsu;C;Chen;J;Dai;M;Bai;L;Yen;C;Wang;T;Hsieh;Y;Lin;J;Chiu;T;Cheng;H;Yang;Y;Hsiao;C;Chen;L;Chen;M |
| 國家衛生研究院 |
2021-05 |
TCOG T5217 trial: A phase II randomized study of SLOG versus modified FOLFIRINOX as the first-line treatment in locally advanced or metastatic pancreatic ductal adenocarcinoma
|
Chiang, NJ;Shan, YS;Bai, LY;Li, CP;Chen, JS;Yang, SH;Kuo, YC;Chao, Y;Hsieh, YY;Kao, HF;Hsiao, CF;Chen, LT |
| 國立成功大學 |
2024-09 |
TCOG T5221 trial: A phase II randomized study of gemcitabine and nab-paclitaxel in combination with S-1/LV (GASL) or oxaliplatin (GAP) as first-line treatment for metastatic pancreatic cancer
|
Su;Y-Y;Bai;L-Y;Huang;C-J;Chiu;C-F;Wang;H-T;Du;J-S;Wang;H-C;Chuang;S;Shih;Y-H;Lin;H-C;Shan;Y-S;Chen;L-T |
